New Treatment Brings Hope for Primary Hyperoxaluria Type 1 Patients in the UAE
The Emirates Medical Association for Nephrology and Transplant (EMANT) Society has announced the introduction of a new medicine for the treatment of Primary Hyperoxaluria Type 1 (PH1) at a medical event held at the Conrad Hotel, Dubai. The event was organized by NewBridge Pharmaceuticals and featured leading nephrology and healthcare
